{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:49:23Z","timestamp":1792273763217,"version":"4.4.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T00:00:00Z","timestamp":1510272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00406-017-0847-1","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T05:29:48Z","timestamp":1510291788000},"page":"541-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort"],"prefix":"10.1007","volume":"268","author":[{"name":"the FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3249-2030","authenticated-orcid":false,"given":"G.","family":"Fond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Resseguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sch\u00fcrhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Godin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Andrianarisoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Brunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bulzacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Aouizerate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Berna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Capdevielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Chereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dubertret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dubreucq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Faget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gabayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Misdrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Passerieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schandrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Urbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Vidailhet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,10]]},"reference":[{"key":"847_CR1","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","volume":"25","author":"R Strawbridge","year":"2015","unstructured":"Strawbridge R, Arnone D, Danese A et al (2015) Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol 25:1532\u20131543","journal-title":"Eur Neuropsychopharmacol"},{"key":"847_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","volume":"150","author":"V Valkanova","year":"2013","unstructured":"Valkanova V, Ebmeier KP, Allan CL (2013) CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 150:736\u2013744. \n                        https:\/\/doi.org\/10.1016\/j.jad.2013.06.004","journal-title":"J Affect Disord"},{"key":"847_CR3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jad.2013.04.039","volume":"150","author":"F Dickerson","year":"2013","unstructured":"Dickerson F, Stallings C, Origoni A et al (2013) Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder. J Affect Disord 150:456\u2013459","journal-title":"J Affect Disord"},{"key":"847_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/schbul\/sbv002","volume":"41","author":"G Fond","year":"2015","unstructured":"Fond G, d\u2019Albis M-A, Jamain S et al (2015) The promise of biological markers for treatment response in first-episode psychosis: a systematic review. Schizophr Bull 41:559\u2013573. \n                        https:\/\/doi.org\/10.1093\/schbul\/sbv002","journal-title":"Schizophr Bull"},{"key":"847_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pnpbp.2013.09.017","volume":"48","author":"AL Lopresti","year":"2014","unstructured":"Lopresti AL, Maker GL, Hood SD, Drummond PD (2014) A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Prog Neuropsychopharmacol Biol Psychiatry 48:102\u2013111. \n                        https:\/\/doi.org\/10.1016\/j.pnpbp.2013.09.017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"847_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/mp.2015.87","volume":"21","author":"BS Fernandes","year":"2016","unstructured":"Fernandes BS, Steiner J, Bernstein H-G et al (2016) C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry 21:554\u2013564. \n                        https:\/\/doi.org\/10.1038\/mp.2015.87","journal-title":"Mol Psychiatry"},{"key":"847_CR7","doi-asserted-by":"publisher","first-page":"26105","DOI":"10.1038\/srep26105","volume":"6","author":"M Inoshita","year":"2016","unstructured":"Inoshita M, Numata S, Tajima A et al (2016) A significant causal association between C-reactive protein levels and schizophrenia. Sci Rep 6:26105. \n                        https:\/\/doi.org\/10.1038\/srep26105","journal-title":"Sci Rep"},{"key":"847_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbw029","author":"E Bulzacka","year":"2016","unstructured":"Bulzacka E, Boyer L, Sch\u00fcrhoff F et al (2016) Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset. Schizophr Bull. \n                        https:\/\/doi.org\/10.1093\/schbul\/sbw029","journal-title":"Schizophr Bull"},{"key":"847_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/acps.12211","volume":"129","author":"G Fond","year":"2014","unstructured":"Fond G, Hamdani N, Kapczinski F et al (2014) Effectiveness and tolerance of anti-inflammatory drugs\u2019 add-on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr Scand 129:163\u2013179. \n                        https:\/\/doi.org\/10.1111\/acps.12211","journal-title":"Acta Psychiatr Scand"},{"key":"847_CR10","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/schbul\/sbt070","volume":"39","author":"M Nitta","year":"2013","unstructured":"Nitta M, Kishimoto T, M\u00fcller N et al (2013) Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull 39:1230\u20131241. \n                        https:\/\/doi.org\/10.1093\/schbul\/sbt070","journal-title":"Schizophr Bull"},{"key":"847_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/schbul\/sbt139","volume":"40","author":"IE Sommer","year":"2013","unstructured":"Sommer IE, van Westrhenen R, Begemann MJ et al (2013) Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull 40:181\u2013191 (sbt139)","journal-title":"Schizophr Bull"},{"key":"847_CR12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.9758\/cpn.2013.11.3.144","volume":"11","author":"MM Al-Amin","year":"2013","unstructured":"Al-Amin MM, Nasir Uddin MM, Mahmud Reza H (2013) Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin Psychopharmacol Neurosci 11:144\u2013151. \n                        https:\/\/doi.org\/10.9758\/cpn.2013.11.3.144","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"847_CR13","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00213-015-4079-7","volume":"233","author":"IE Cruz Jung da","year":"2016","unstructured":"da Cruz Jung IE, Machado AK, da Cruz IBM et al (2016) Haloperidol and Risperidone at high concentrations activate an in vitro inflammatory response of RAW 264.7 macrophage cells by induction of apoptosis and modification of cytokine levels. Psychopharmacology 233:1715\u20131723. \n                        https:\/\/doi.org\/10.1007\/s00213-015-4079-7","journal-title":"Psychopharmacology"},{"key":"847_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.schres.2014.02.005","volume":"154","author":"L Witte de","year":"2014","unstructured":"de Witte L, Tomasik J, Schwarz E et al (2014) Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res 154:23\u201329. \n                        https:\/\/doi.org\/10.1016\/j.schres.2014.02.005","journal-title":"Schizophr Res"},{"key":"847_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.03.039","author":"R Handley","year":"2016","unstructured":"Handley R, Mondelli V, Zelaya F et al (2016) Effects of antipsychotics on cortisol, interleukin-6 and hippocampal perfusion in healthy volunteers. Schizophr Res. \n                        https:\/\/doi.org\/10.1016\/j.schres.2016.03.039","journal-title":"Schizophr Res"},{"key":"847_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.schres.2007.01.019","volume":"92","author":"T Kato","year":"2007","unstructured":"Kato T, Monji A, Hashioka S, Kanba S (2007) Risperidone significantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr Res 92:108\u2013115. \n                        https:\/\/doi.org\/10.1016\/j.schres.2007.01.019","journal-title":"Schizophr Res"},{"key":"847_CR17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuropharm.2006.07.006","volume":"51","author":"E-JD Lin","year":"2006","unstructured":"Lin E-JD, Lee NJ, Slack K et al (2006) Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats. Neuropharmacology 51:1129\u20131136. \n                        https:\/\/doi.org\/10.1016\/j.neuropharm.2006.07.006","journal-title":"Neuropharmacology"},{"key":"847_CR18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W et al (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70:663\u2013671","journal-title":"Biol Psychiatry"},{"key":"847_CR19","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s12031-012-9852-z","volume":"49","author":"A Morag","year":"2013","unstructured":"Morag A, Oved K, Gurwitz D (2013) Sex differences in human lymphoblastoid cells sensitivities to antipsychotic drugs. J Mol Neurosci MN 49:554\u2013558. \n                        https:\/\/doi.org\/10.1007\/s12031-012-9852-z","journal-title":"J Mol Neurosci MN"},{"key":"847_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejphar.2015.03.003","volume":"755","author":"H Shin","year":"2015","unstructured":"Shin H, Kim J, Song J-H (2015) Clozapine and olanzapine inhibit proton currents in BV2 microglial cells. Eur J Pharmacol 755:74\u201379. \n                        https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.003","journal-title":"Eur J Pharmacol"},{"key":"847_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","volume":"33","author":"H Sugino","year":"2009","unstructured":"Sugino H, Futamura T, Mitsumoto Y et al (2009) Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 33:303\u2013307. \n                        https:\/\/doi.org\/10.1016\/j.pnpbp.2008.12.006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"847_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejps.2015.10.010","volume":"81","author":"N Todorovi\u0107","year":"2016","unstructured":"Todorovi\u0107 N, Tomanovi\u0107 N, Gass P, Filipovi\u0107 D (2016) Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats. Eur J Pharm Sci 81:94\u2013102. \n                        https:\/\/doi.org\/10.1016\/j.ejps.2015.10.010","journal-title":"Eur J Pharm Sci"},{"key":"847_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/glia.22610","volume":"62","author":"E Valera","year":"2014","unstructured":"Valera E, Ubhi K, Mante M et al (2014) Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy. Glia 62:317\u2013337. \n                        https:\/\/doi.org\/10.1002\/glia.22610","journal-title":"Glia"},{"key":"847_CR24","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1038\/sj.npp.1300756","volume":"30","author":"XY Zhang","year":"2005","unstructured":"Zhang XY, Zhou DF, Cao LY et al (2005) Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Neuropsychopharmacology 30:1532\u20131538. \n                        https:\/\/doi.org\/10.1038\/sj.npp.1300756","journal-title":"Neuropsychopharmacology"},{"key":"847_CR25","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, DellaGioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36:2452\u20132459","journal-title":"Neuropsychopharmacology"},{"key":"847_CR26","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1017\/S0033291712000128","volume":"42","author":"SA Hiles","year":"2012","unstructured":"Hiles SA, Baker AL, de Malmanche T, Attia J (2012) Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis. Psychol Med 42:2015\u20132026. \n                        https:\/\/doi.org\/10.1017\/S0033291712000128","journal-title":"Psychol Med"},{"key":"847_CR27","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","volume":"25","author":"R Strawbridge","year":"2015","unstructured":"Strawbridge R, Arnone D, Danese A et al (2015) Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 25:1532\u20131543. \n                        https:\/\/doi.org\/10.1016\/j.euroneuro.2015.06.007","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"847_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jad.2015.11.017","volume":"191","author":"G Fond","year":"2016","unstructured":"Fond G, Godin O, Brunel L et al (2016) Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. results from the multi-center FACE-SZ data set. J Affect Disord 191:209\u2013215. \n                        https:\/\/doi.org\/10.1016\/j.jad.2015.11.017","journal-title":"J Affect Disord"},{"key":"847_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jad.2016.06.016","volume":"203","author":"S Ameele van den","year":"2016","unstructured":"van den Ameele S, van Diermen L, Staels W et al (2016) The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: a systematic review. J Affect Disord 203:364\u2013373. \n                        https:\/\/doi.org\/10.1016\/j.jad.2016.06.016","journal-title":"J Affect Disord"},{"key":"847_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/JCP.0000000000000109","volume":"34","author":"S-Y Lee","year":"2014","unstructured":"Lee S-Y, Chen S-L, Chang Y-H et al (2014) The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial. J Clin Psychopharmacol 34:337\u2013343. \n                        https:\/\/doi.org\/10.1097\/JCP.0000000000000109","journal-title":"J Clin Psychopharmacol"},{"key":"847_CR31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","volume":"29","author":"M Maes","year":"1995","unstructured":"Maes M, Bosmans E, Calabrese J et al (1995) Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 29:141\u2013152","journal-title":"J Psychiatr Res"},{"key":"847_CR32","doi-asserted-by":"publisher","first-page":"e00130","DOI":"10.1016\/j.heliyon.2016.e00130","volume":"2","author":"AM El-Mowafy","year":"2016","unstructured":"El-Mowafy AM, Katary MM, Pye C et al (2016) Novel molecular triggers underlie valproate-induced liver injury and its alleviation by the omega-3 fatty acid DHA: role of inflammation and apoptosis. Heliyon 2:e00130. \n                        https:\/\/doi.org\/10.1016\/j.heliyon.2016.e00130","journal-title":"Heliyon"},{"key":"847_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004052","author":"K Macritchie","year":"2003","unstructured":"Macritchie K, Geddes JR, Scott J et al (2003) Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. \n                        https:\/\/doi.org\/10.1002\/14651858.CD004052","journal-title":"Cochrane Database Syst Rev"},{"key":"847_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/gerona\/glr003","volume":"66","author":"Y Yang","year":"2011","unstructured":"Yang Y, Kozloski M (2011) Sex differences in age trajectories of physiological dysregulation: inflammation, metabolic syndrome, and allostatic load. J Gerontol A Biol Sci Med Sci 66:493\u2013500. \n                        https:\/\/doi.org\/10.1093\/gerona\/glr003","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"847_CR35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3371\/CSRP.MICU.020813","volume":"7","author":"BJ Miller","year":"2014","unstructured":"Miller BJ, Culpepper N, Rapaport MH (2014) C-reactive protein levels in schizophrenia. Clin Schizophr Relat Psychoses 7:223\u2013230","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"847_CR36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1037\/1082-989X.7.1.19","volume":"7","author":"RC MacCallum","year":"2002","unstructured":"MacCallum RC, Zhang S, Preacher KJ, Rucker DD (2002) On the practice of dichotomization of quantitative variables. Psychol Methods 7:19\u201340","journal-title":"Psychol Methods"},{"key":"847_CR37","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/bmj.312.7033.770","volume":"312","author":"JM Bland","year":"1996","unstructured":"Bland JM, Altman DG (1996) Transforming data. BMJ 312:770","journal-title":"BMJ"},{"key":"847_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3969\/j.issn.1002-0829.2014.02.009","volume":"26","author":"C Feng","year":"2014","unstructured":"Feng C, Wang H, Lu N et al (2014) Log-transformation and its implications for data analysis. Shanghai Arch Psychiatry 26:105\u2013109. \n                        https:\/\/doi.org\/10.3969\/j.issn.1002-0829.2014.02.009","journal-title":"Shanghai Arch Psychiatry"},{"key":"847_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/sim.5486","volume":"32","author":"C Feng","year":"2013","unstructured":"Feng C, Wang H, Lu N, Tu XM (2013) Log transformation: application and interpretation in biomedical research. Stat Med 32:230\u2013239. \n                        https:\/\/doi.org\/10.1002\/sim.5486","journal-title":"Stat Med"},{"key":"847_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1037\/a0029508","volume":"27","author":"DC Atkins","year":"2013","unstructured":"Atkins DC, Baldwin SA, Zheng C et al (2013) A tutorial on count regression and zero-altered count models for longitudinal substance use data. Psychol Addict Behav J Soc Psychol Addict Behav 27:166\u2013177. \n                        https:\/\/doi.org\/10.1037\/a0029508","journal-title":"Psychol Addict Behav J Soc Psychol Addict Behav"},{"key":"847_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2015.05.004","author":"F Sch\u00fcrhoff","year":"2015","unstructured":"Sch\u00fcrhoff F, Fond G, Berna F et al (2015) A National network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap. Eur Psychiatry J Assoc Eur Psychiatr. \n                        https:\/\/doi.org\/10.1016\/j.eurpsy.2015.05.004","journal-title":"Eur Psychiatry J Assoc Eur Psychiatr"},{"key":"847_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276","journal-title":"Schizophr Bull"},{"key":"847_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1191\/1471082X05st084oa","volume":"5","author":"Y Min","year":"2005","unstructured":"Min Y, Agresti A (2005) Random effect models for repeated measures of zero-inflated count data. Stat Model 5:1\u201319. \n                        https:\/\/doi.org\/10.1191\/1471082X05st084oa","journal-title":"Stat Model"},{"key":"847_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000441521","volume":"2","author":"TM Fonseka","year":"2016","unstructured":"Fonseka TM, M\u00fcller DJ, Kennedy SH (2016) Inflammatory cytokines and antipsychotic-induced weight gain: review and clinical implications. Mol Neuropsychiatry 2:1\u201314. \n                        https:\/\/doi.org\/10.1159\/000441521","journal-title":"Mol Neuropsychiatry"},{"key":"847_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2015.07.047","author":"O Godin","year":"2015","unstructured":"Godin O, Leboyer M, Gaman A et al (2015) Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: results from the FACE-SZ cohort. Schizophr Res. \n                        https:\/\/doi.org\/10.1016\/j.schres.2015.07.047","journal-title":"Schizophr Res"},{"key":"847_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4077\/CJP.2016.BAE370","volume":"59","author":"Y-C Kao","year":"2016","unstructured":"Kao Y-C, Ko C-Y, Wang S-C, Liu Y-P (2016) Protective effects of quetiapine on metabolic and inflammatory abnormalities in schizophrenic patients during exacerbated stage. Chin J Physiol 59:69\u201377. \n                        https:\/\/doi.org\/10.4077\/CJP.2016.BAE370","journal-title":"Chin J Physiol"},{"key":"847_CR47","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.bbrc.2014.07.005","volume":"450","author":"AK S\u00e1rv\u00e1ri","year":"2014","unstructured":"S\u00e1rv\u00e1ri AK, Ver\u00e9b Z, Uray IP et al (2014) Atypical antipsychotics induce both proinflammatory and adipogenic gene expression in human adipocytes in vitro. Biochem Biophys Res Commun 450:1383\u20131389. \n                        https:\/\/doi.org\/10.1016\/j.bbrc.2014.07.005","journal-title":"Biochem Biophys Res Commun"},{"key":"847_CR48","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.biopsych.2009.06.005","volume":"66","author":"JM Meyer","year":"2009","unstructured":"Meyer JM, McEvoy JP, Davis VG et al (2009) Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Biol Psychiatry 66:1013\u20131022. \n                        https:\/\/doi.org\/10.1016\/j.biopsych.2009.06.005","journal-title":"Biol Psychiatry"},{"key":"847_CR49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2147\/DDDT.S89485","volume":"10","author":"N Maneeton","year":"2016","unstructured":"Maneeton N, Maneeton B, Woottiluk P et al (2016) Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials. Drug Des Dev Ther 10:259\u2013276. \n                        https:\/\/doi.org\/10.2147\/DDDT.S89485","journal-title":"Drug Des Dev Ther"},{"key":"847_CR50","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1365-2036.2012.05007.x","volume":"35","author":"C Chassard","year":"2012","unstructured":"Chassard C, Dapoigny M, Scott KP et al (2012) Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther 35:828\u2013838. \n                        https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05007.x","journal-title":"Aliment Pharmacol Ther"},{"key":"847_CR51","first-page":"836","volume":"87","author":"G Zoppi","year":"1992","unstructured":"Zoppi G, Cinquetti M, Luciano A et al (1992) The intestinal ecosystem in chronic functional constipation. Acta Paediatr Oslo Nor 1992 87:836\u2013841","journal-title":"Acta Paediatr Oslo Nor 1992"},{"key":"847_CR52","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.schres.2013.05.018","volume":"148","author":"EG Severance","year":"2013","unstructured":"Severance EG, Gressitt KL, Stallings CR et al (2013) Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res 148:130\u2013137. \n                        https:\/\/doi.org\/10.1016\/j.schres.2013.05.018","journal-title":"Schizophr Res"},{"key":"847_CR53","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.encep.2008.03.007","volume":"35","author":"P Bret","year":"2009","unstructured":"Bret P, Bret M-C, Queuille E (2009) Enqu\u00eate de pratiques de prescription des antipsychotiques dans 13 centres hospitaliers du r\u00e9seau PIC. L\u2019Enc\u00e9phale 35:129\u2013138. \n                        https:\/\/doi.org\/10.1016\/j.encep.2008.03.007","journal-title":"L\u2019Enc\u00e9phale"},{"key":"847_CR54","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4088\/JCP.v60n0701","volume":"60","author":"SM Stahl","year":"1999","unstructured":"Stahl SM (1999) Antipsychotic polypharmacy, part 1: therapeutic option or dirty little secret?: (Brainstorms). J Clin Psychiatry 60:425\u2013426. \n                        https:\/\/doi.org\/10.4088\/JCP.v60n0701","journal-title":"J Clin Psychiatry"},{"key":"847_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biopsych.2015.05.014","volume":"80","author":"MR Irwin","year":"2016","unstructured":"Irwin MR, Olmstead R, Carroll JE (2016) Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry 80:40\u201352. \n                        https:\/\/doi.org\/10.1016\/j.biopsych.2015.05.014","journal-title":"Biol Psychiatry"},{"key":"847_CR56","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1089\/neu.2015.4163","volume":"33","author":"T Bambakidis","year":"2016","unstructured":"Bambakidis T, Dekker SE, Sillesen M et al (2016) Resuscitation with valproic acid alters inflammatory genes in a porcine model of combined traumatic brain injury and hemorrhagic shock. J Neurotrauma 33:1514\u20131521. \n                        https:\/\/doi.org\/10.1089\/neu.2015.4163","journal-title":"J Neurotrauma"},{"key":"847_CR57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.intimp.2016.08.008","volume":"39","author":"AM Kabel","year":"2016","unstructured":"Kabel AM, Omar MS, Elmaaboud MAA (2016) Amelioration of bleomycin-induced lung fibrosis in rats by valproic acid and butyrate: role of nuclear factor kappa-B, proinflammatory cytokines and oxidative stress. Int Immunopharmacol 39:335\u2013342. \n                        https:\/\/doi.org\/10.1016\/j.intimp.2016.08.008","journal-title":"Int Immunopharmacol"},{"key":"847_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25604","author":"S-J Leu","year":"2016","unstructured":"Leu S-J, Yang Y-Y, Liu H-C et al (2016) Valproic acid and lithium meditate anti-inflammatory effects by differentially modulating dendritic cell differentiation and function. J Cell Physiol. \n                        https:\/\/doi.org\/10.1002\/jcp.25604","journal-title":"J Cell Physiol"},{"key":"847_CR59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jpsychires.2015.02.011","volume":"63","author":"G Fond","year":"2015","unstructured":"Fond G, Boyer L, Gaman A et al (2015) Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study. J Psychiatr Res 63:58\u201364. \n                        https:\/\/doi.org\/10.1016\/j.jpsychires.2015.02.011","journal-title":"J Psychiatr Res"},{"key":"847_CR60","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s10753-017-0574-9","volume":"40","author":"MA Amirzargar","year":"2017","unstructured":"Amirzargar MA, Yaghubi F, Hosseinipanah M et al (2017) Anti-inflammatory effects of valproic acid in a rat model of renal ischemia\/reperfusion injury: alteration in cytokine profile. Inflammation 40:1310\u20131318. \n                        https:\/\/doi.org\/10.1007\/s10753-017-0574-9","journal-title":"Inflammation"},{"key":"847_CR61","doi-asserted-by":"publisher","first-page":"488","DOI":"10.5152\/balkanmedj.2016.151304","volume":"33","author":"F Ho\u015fg\u00f6rler","year":"2016","unstructured":"Ho\u015fg\u00f6rler F, Kele\u015f D, Tanr\u0131verdi-Akhisaro\u011flu S et al (2016) Anti-inflammatory and anti-apoptotic effect of valproic acid and doxycycline independent from MMP inhibition in early radiation damage. Balk Med J 33:488\u2013495. \n                        https:\/\/doi.org\/10.5152\/balkanmedj.2016.151304","journal-title":"Balk Med J"},{"key":"847_CR62","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/jcp.25604","volume":"232","author":"S-J Leu","year":"2017","unstructured":"Leu S-J, Yang Y-Y, Liu H-C et al (2017) Valproic acid and lithium meditate anti-inflammatory effects by differentially modulating dendritic cell differentiation and function. J Cell Physiol 232:1176\u20131186. \n                        https:\/\/doi.org\/10.1002\/jcp.25604","journal-title":"J Cell Physiol"},{"key":"847_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-013-0413-4","author":"G Fond","year":"2013","unstructured":"Fond G, Macgregor A, Tamouza R et al (2013) Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate. Eur Arch Psychiatry Clin Neurosci. \n                        https:\/\/doi.org\/10.1007\/s00406-013-0413-4","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"847_CR64","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3389\/fmicb.2017.00815","volume":"8","author":"AO Ogundeji","year":"2017","unstructured":"Ogundeji AO, Pohl CH, Sebolai OM (2017) The repurposing of anti-psychotic drugs, quetiapine and olanzapine, as anti-cryptococcus drugs. Front Microbiol 8:815. \n                        https:\/\/doi.org\/10.3389\/fmicb.2017.00815","journal-title":"Front Microbiol"},{"key":"847_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.lfs.2017.04.024","volume":"179","author":"R Bahramabadi","year":"2017","unstructured":"Bahramabadi R, Samadi M, Vakilian A et al (2017) Evaluation of the effects of anti-psychotic drugs on the expression of CD68 on the peripheral blood monocytes of Alzheimer patients with psychotic symptoms. Life Sci 179:73\u201379. \n                        https:\/\/doi.org\/10.1016\/j.lfs.2017.04.024","journal-title":"Life Sci"},{"key":"847_CR66","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.pbb.2015.05.021","volume":"135","author":"EJ Jaehne","year":"2015","unstructured":"Jaehne EJ, Corrigan F, Toben C et al (2015) The effect of the antipsychotic drug quetiapine and its metabolite norquetiapine on acute inflammation, memory and anhedonia. Pharmacol Biochem Behav 135:136\u2013144. \n                        https:\/\/doi.org\/10.1016\/j.pbb.2015.05.021","journal-title":"Pharmacol Biochem Behav"},{"key":"847_CR67","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeier KP et al (2015) Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder. Brain Behav Immun 49:206\u2013215. \n                        https:\/\/doi.org\/10.1016\/j.bbi.2015.06.001","journal-title":"Brain Behav Immun"},{"key":"847_CR68","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s11302-015-9467-2","volume":"11","author":"P Dao-Ung","year":"2015","unstructured":"Dao-Ung P, Skarratt KK, Fuller SJ, Stokes L (2015) Paroxetine suppresses recombinant human P2X7 responses. Purinergic Signal 11:481\u2013490. \n                        https:\/\/doi.org\/10.1007\/s11302-015-9467-2","journal-title":"Purinergic Signal"},{"key":"847_CR69","doi-asserted-by":"publisher","first-page":"L507","DOI":"10.1152\/ajplung.00242.2015","volume":"310","author":"J Gaydos","year":"2016","unstructured":"Gaydos J, McNally A, Guo R et al (2016) Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells. Am J Physiol Lung Cell Mol Physiol 310:L507\u2013L518. \n                        https:\/\/doi.org\/10.1152\/ajplung.00242.2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"847_CR70","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1507\/endocrj.EJ14-0262","volume":"61","author":"JH Kim","year":"2014","unstructured":"Kim JH, Cho HT, Kim YJ (2014) The role of estrogen in adipose tissue metabolism: insights into glucose homeostasis regulation. Endocr J 61:1055\u20131067","journal-title":"Endocr J"},{"key":"847_CR71","first-page":"8197","volume":"8","author":"X Li","year":"2015","unstructured":"Li X, Zhang J, Zhu X et al (2015) Progesterone reduces inflammation and apoptosis in neonatal rats with hypoxic ischemic brain damage through the PI3K\/Akt pathway. Int J Clin Exp Med 8:8197\u20138203","journal-title":"Int J Clin Exp Med"},{"key":"847_CR72","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.schres.2015.08.019","volume":"168","author":"J Joseph","year":"2015","unstructured":"Joseph J, Depp C, Martin AS et al (2015) Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups. Schizophr Res 168:456\u2013460. \n                        https:\/\/doi.org\/10.1016\/j.schres.2015.08.019","journal-title":"Schizophr Res"},{"issue":"Suppl 2","key":"847_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/15622970510030027","volume":"6","author":"AC Altamura","year":"2005","unstructured":"Altamura AC, Bassetti R, Cattaneo E, Vismara S (2005) Some biological correlates of drug resistance in schizophrenia: a multidimensional approach. World J Biol Psychiatry 6(Suppl 2):23\u201330. \n                        https:\/\/doi.org\/10.1080\/15622970510030027","journal-title":"World J Biol Psychiatry"},{"key":"847_CR74","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.schres.2015.07.003","volume":"168","author":"B Stubbs","year":"2015","unstructured":"Stubbs B, Gardner-Sood P, Smith S et al (2015) Sedentary behaviour is associated with elevated C-reactive protein levels in people with psychosis. Schizophr Res 168:461\u2013464. \n                        https:\/\/doi.org\/10.1016\/j.schres.2015.07.003","journal-title":"Schizophr Res"},{"key":"847_CR75","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1741-7015-11-200","volume":"11","author":"M Berk","year":"2013","unstructured":"Berk M, Williams LJ, Jacka FN et al (2013) So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 11:200. \n                        https:\/\/doi.org\/10.1186\/1741-7015-11-200","journal-title":"BMC Med"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-017-0847-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-017-0847-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-017-0847-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T03:19:59Z","timestamp":1533871199000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-017-0847-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,10]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1007\/s00406-017-0847-1","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,10]]}}}